Beth Marsh joined Neurotech in April 2025 as the Company’s Chief Commercial Officer.

Beth has 25 years of ophthalmic and retina industry experience at public and private biotech companies. And has successfully launched numerous ophthalmic products.

Prior to joining Neurotech, she held the position of Vice President, North America Sales and Marketing in Ophthalmology for Apellis Pharmaceuticals and previously served in commercial leadership roles at Shire / Takeda Pharmaceuticals as Global Product Strategy Lead, Ophthalmology.

Earlier in her career she held ophthalmic commercial and business development
leadership roles with Aciex Therapeutics, Johnson and Johnson Vision Care, and Santen.
Beth is a long-time non-profit leader and past president of OWL: Advancing diversity in
leadership in ophthalmology.

Beth holds a bachelor’s in business administration in Marketing from Miami University.